NLM Digital Collections

Search

Start Over Subjects Government Regulation ✖Remove constraint Subjects: Government Regulation

261. Some manufacturers reported inaccurate drug product data to CMS

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Data Accuracy
Drug Industry -- legislation & jurisprudence
Government Regulation
Medicare Part B -- economics
Pharmaceutical Preparations -- economics
United States
United States. Department of Health and Human Services

262. National Background Check Program for long-term-care providers: assessment of state programs concluded in 2019

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Government Regulation
Health Workforce -- legislation & jurisprudence
Long-Term Care -- standards
Patient Safety -- legislation & jurisprudence
United States
United States. Department of Health and Human Services

263. FDA’s risk evaluation and mitigation strategies: uncertain effectiveness in addressing the opioid crisis

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Government Regulation
Opioid-Related Disorders -- economics
Risk Evaluation and Mitigation -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

264. CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Government Regulation
Medicaid -- economics
Naloxone -- supply & distribution
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

265. Opioids in Medicaid: concerns about opioid use among beneficiaries in six Appalachian states in 2018

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, December 2020
Subject(s):
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicaid -- legislation & jurisprudence
Opioid-Related Disorders -- prevention & control
Appalachian Region
United States
United States. Department of Health and Human Services

267. Few patients received high amounts of opioids from IHS-run pharmacies

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2020
Subject(s):
Analgesics, Opioid -- supply & distribution
Government Regulation
Pharmacies
Prescription Drug Monitoring Programs -- organization & administration
United States
United States. Department of Health and Human Services
United States. Indian Health Service

268. Indian Health Service facilities made progress incorporating patient protection policies, but challenges remain

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2020
Subject(s):
Child Abuse, Sexual -- prevention & control
Government Regulation
Patient Safety -- legislation & jurisprudence
Policy
Professional Misconduct -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
United States. Indian Health Service

269. Despite savings on many lab tests in 2019, total Medicare spending increased slightly because of increased utilization for certain high-priced tests

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2020
Subject(s):
Diagnostic Techniques and Procedures -- economics
Genetic Testing -- economics
Government Regulation
Medicare -- economics
United States
United States. Department of Health and Human Services

270. Incidence of adverse events in Indian Health Service hospitals

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2020
Subject(s):
Government Regulation
Hospitals, Public -- statistics & numerical data
Patient Harm -- statistics & numerical data
United States
United States. Department of Health and Human Services
United States. Indian Health Service